More blood pressure medication recalled: Company recalls 80 lots of valsartan over cancer concerns January 2, 2019 Geist Patrol AdminIndiana Crime News Aurobindo Pharma USA, Inc. is voluntarily recalling valsartan tablets that might include N-nitrosodiethylamine (NDEA), a possible human carcinogen. Share on Facebook Share Share on TwitterTweet Share on Pinterest Share Share on LinkedIn Share Share on Digg Share Send email Mail Print Print